• 40557 Citations
  • 99 Scopus h-Index
1980 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk

ENGAGE Consortium Telomere Group, 2015, In : Oncotarget. 6, 40, p. 42468-42477 10 p.

Research output: Contribution to journalArticle

41 Scopus citations

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy

Frost, M. H., Schaid, D. J., Sellers, T. A., Slezak, J. M., Arnold, P. G., Woods, J. E., Petty, P. M., Johnson, J. L., Sitta, D. L., McDonnell, S. K., Rummans, T. A., Jenkins, R. B., Sloan, J. A. & Hartmann, L. C., Jul 19 2000, In : Journal of the American Medical Association. 284, 3, p. 319-324 6 p.

Research output: Contribution to journalArticle

248 Scopus citations

Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections

Burger, P. C., Minn, A. Y., Smith, J. S., Borell, T. J., Jedlicka, A. E., Huntley, B. K., Goldthwaite, P. T., Jenkins, R. B. & Feuerstein, B. G., 2001, In : Modern Pathology. 14, 9, p. 842-853 12 p.

Research output: Contribution to journalArticle

99 Scopus citations

Loss of expression of the DRR I gene at chromosomal segment 3p21.1 in Renal cell carcinoma

Wang, L., Darling, J., Zhang, J. S., Liu, W., Qian, J., Bostwick, D., Hartmann, L., Jenkins, R. B., Bardenhauer, W., Schutte, J., Opalka, B. & Smith, D. I., Jan 2000, In : Genes Chromosomes and Cancer. 27, 1, p. 1-10 10 p.

Research output: Contribution to journalArticle

51 Scopus citations

Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer

Villeneuve, J. B., Silverman, M. B., Alderete, B., Cliby, W. A., Li, H., Croghan, G. A., Podratz, K. C. & Jenkins, R. B., May 1999, In : Genes Chromosomes and Cancer. 25, 1, p. 65-69 5 p.

Research output: Contribution to journalArticle

7 Scopus citations

Loss of p53 and c-myc overrepresentation in stage T2-3 N1-3M0 prostate cancer are potential markers for cancer progression

Qian, J., Hirasawa, K., Bostwick, D. G., Bergstralh, E. J., Slezak, J. M., Anderl, K. L., Borell, T. J., Lieber, M. M. & Jenkins, R. B., 2002, In : Modern Pathology. 15, 1, p. 35-44 10 p.

Research output: Contribution to journalArticle

77 Scopus citations

Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer

Tsuchiya, N., Kondo, Y., Takahashi, A., Pawar, H., Qian, J., Sato, K., Lieber, M. M. & Jenkins, R. B., 2002, In : American Journal of Pathology. 160, 5, p. 1799-1806 8 p.

Research output: Contribution to journalArticle

34 Scopus citations

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

Smith, J. S., Tachibana, I., Lee, H. K., Qian, J., Pohl, U., Mohrenweiser, H. W., Borell, T. J., Hosek, S. M., Soderberg, C. L., Von Deimling, A., Perry, A., Scheithauer, B. W., Louis, D. N. & Jenkins, R. B., Sep 2000, In : Genes Chromosomes and Cancer. 29, 1, p. 16-25 10 p.

Research output: Contribution to journalArticle

78 Scopus citations

Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia

Aypar, U., Smoley, S. A., Pitel, B. A., Pearce, K. E., Zenka, R. M., Vasmatzis, G., Johnson, S. H., Smadbeck, J., Peterson, J. F., Geiersbach, K. B., Van Dyke, D. L., Thorland, E. C., Jenkins, R. B., Ketterling, R. P., Greipp, P. T., Kearney, H. M., Hoppman, N. L. & Baughn, L., Jan 1 2019, In : European Journal of Haematology. 102, 1, p. 87-96 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Medulloblastoma: II. A pathobiologic overview

Tomlinson, F. H., Scheithauer, B. W. & Jenkins, R. B., 1992, In : Journal of Child Neurology. 7, 3, p. 240-252 13 p.

Research output: Contribution to journalArticle

14 Scopus citations

Mendelian randomisation study of the relationship between Vitamin D and risk of glioma

Takahashi, H., Cornish, A. J., Sud, A., Law, P. J., Kinnersley, B., Ostrom, Q. T., Labreche, K., Eckel-Passow, J. E., Armstrong, G. N., Claus, E. B., Ll'Yasova, D., Schildkraut, J., Barnholtz-Sloan, J. S., Olson, S. H., Bernstein, J. L., Lai, R. K., Schoemaker, M. J., Simon, M., Hoffmann, P., Nöthen, M. M. & 11 others, Jöckel, K. H., Chanock, S., Rajaraman, P., Johansen, C., Jenkins, R. B., Melin, B. S., Wrensch, M. R., Sanson, M., Bondy, M. L., Turnbull, C. & Houlston, R. S., Dec 1 2018, In : Scientific Reports. 8, 1, 2339.

Research output: Contribution to journalArticle

5 Scopus citations

Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development

Brisbin, A. G., Asmann, Y., Song, H., Tsai, Y. Y., Aakre, J. A., Yang, P., Jenkins, R. B., Pharoah, P., Schumacher, F., Conti, D. V., Duggan, D. J., Jenkins, M., Hopper, J., Gallinger, S., Newcomb, P., Casey, G., Sellers, T. A. & Fridley, B. L., Dec 5 2011, In : BMC Medical Genetics. 12, 156.

Research output: Contribution to journalArticle

22 Scopus citations

Metastatic prostate carcinoma to bone: Clinical and pathologic features associated with cancer-specific survival

Cheville, J. C., Tindall, D., Boelter, C., Jenkins, R. B., Lohse, C. M., Pankratz, V. S., Sebo, T. J., Davis, B. & Blute, M. L., Sep 1 2002, In : Cancer. 95, 5, p. 1028-1036 9 p.

Research output: Contribution to journalArticle

104 Scopus citations

MGMT immunohistochemical expression and promoter methylation in human glioblastoma

Rodriguez, F. J., Thibodeau, S. N., Jenkins, R. B., Schowalter, K. V., Caron, B. L., O'Neill, B. P., David James, C., Passe, S., Slezak, J. & Giannini, C., Jan 2008, In : Applied Immunohistochemistry and Molecular Morphology. 16, 1, p. 59-65 7 p.

Research output: Contribution to journalArticle

107 Scopus citations

MGMT immunohistochemical expression and promoter methylation in human glioblastoma (Applied Immunohistochemistry and Molecular Morphology (2008) 16, (59-65))

Rodriguez, F. J., Thibodeau, S. N., Jenkins, R. B., Schowalter, K. V., Caron, B. L., O'Neill, B. P., David James, C., Passe, S., Slezak, J. & Giannini, C., May 2008, In : Applied Immunohistochemistry and Molecular Morphology. 16, 3, p. 307 1 p.

Research output: Contribution to journalArticle

MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2

Das, R., Gregory, P. A., Fernandes, R. C., Denis, I., Wang, Q., Townley, S. L., Zhao, S. G., Hanson, A. R., Pickering, M. A., Armstrong, H. K., Lokman, N. A., Ebrahimie, E., Davicioni, E., Jenkins, R. B., Karnes, R. J., Ross, A. E., Den, R. B., Klein, E. A., Chi, K. N., Ramshaw, H. S. & 7 others, Williams, E. D., Zoubeidi, A., Goodall, G. J., Feng, F. Y., Butler, L. M., Tilley, W. D. & Selth, L. A., Feb 15 2017, In : Cancer Research. 77, 4, p. 1021-1034 14 p.

Research output: Contribution to journalArticle

35 Scopus citations

Microsatellite instability in hereditary and sporadic breast cancers

Adem, C., Soderberg, C. L., Cunningham, J. M., Reynolds, C., Sebo, T. J., Thibodeau, S. N., Hartmann, L. C. & Jenkins, R. B., Nov 20 2003, In : International Journal of Cancer. 107, 4, p. 580-582 3 p.

Research output: Contribution to journalArticle

42 Scopus citations

Modeling megakaryocyte development as a branching process

Therneau, T. M., Solberg, L. A. & Jenkins, R. B., 1989, In : Computers and Mathematics with Applications. 18, 10-11, p. 959-964 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Klein, E. A., Santiago-Jiménez, M., Yousefi, K., Robbins, B. A., Schaeffer, E. M., Trock, B. J., Tosoian, J., Haddad, Z., Ra, S., Karnes, R. J., Jenkins, R. B., Cheville, J. C., Den, R. B., Dicker, A. P., Davicioni, E., Freedland, S. J. & Ross, A. E., Jan 1 2017, In : Journal of Urology. 197, 1, p. 122-128 7 p.

Research output: Contribution to journalArticle

24 Scopus citations

Molecular analysis of metaplastic breast carcinoma: High EGFR copy number via aneusomy

Gilbert, J. A., Goetz, M. P., Reynolds, C. A., Ingle, J. N., Giordano, K. F., Suman, V. J., Blair, H. E., Jenkins, R. B., Lingle, W. L., Reinholz, M. M., Adjei, A. & Ames, M. M., Apr 1 2008, In : Molecular Cancer Therapeutics. 7, 4, p. 944-951 8 p.

Research output: Contribution to journalArticle

49 Scopus citations

Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines

Law, M. E., Templeton, K. L., Kitange, G., Smith, J., Misra, A., Feuerstein, B. G. & Jenkins, R. B., Jul 1 2005, In : Cancer Genetics and Cytogenetics. 160, 1, p. 1-14 14 p.

Research output: Contribution to journalArticle

47 Scopus citations

Molecular genetics of astrocytomas and meningiomas

Dalrymple, S. J. & Jenkins, R. B., 1994, In : Current Opinion in Neurology. 7, 6, p. 477-483 7 p.

Research output: Contribution to journalArticle

17 Scopus citations

Molecular subtyping of tumors from patients with familial glioma

Ruiz, V. Y., Praska, C. E., Armstrong, G., Kollmeyer, T. M., Yamada, S., Decker, P. A., Kosel, M. L., Eckel-Passow, J. E., Lachance, D. H., Bainbridge, M. N., Melin, B. S., Bondy, M. L. & Jenkins, R. B., May 18 2018, In : Neuro-Oncology. 20, 6, p. 810-817 8 p.

Research output: Contribution to journalArticle

2 Scopus citations

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the college of american pathologists, international association for the study of lung cancer, and association for molecular pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jul 2013, In : Journal of Molecular Diagnostics. 15, 4, p. 415-453 39 p.

Research output: Contribution to journalArticle

317 Scopus citations

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the study of lung cancer, and Association for Molecular Pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jun 2013, In : Archives of Pathology and Laboratory Medicine. 137, 6, p. 828-860 33 p.

Research output: Contribution to journalArticle

293 Scopus citations

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jul 2013, In : Journal of Thoracic Oncology. 8, 7, p. 823-859 37 p.

Research output: Contribution to journalArticle

528 Scopus citations

Multi-parametric MRI and texture analysis to visualize spatial histologic heterogeneity and tumor extent in glioblastoma

Hu, L. S., Ning, S., Eschbacher, J. M., Gaw, N., Dueck, A., Smith, K. A., Nakaji, P., Plasencia, J., Ranjbar, S., Price, S. J., Tran, N., Loftus, J. C., Jenkins, R. B., O'Neill, B. P., Elmquist, W., Baxter, L. C., Gao, F., Frakes, D., Karis, J. P., Zwart, C. & 5 others, Swanson, K., Sarkaria, J. N., Wu, T., Mitchell, J. R. & Li, J., Nov 1 2015, In : PLoS One. 10, 11, e0141506.

Research output: Contribution to journalArticle

49 Scopus citations

Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer

Yokomizo, A., Tindall, D. J., Hartmann, L., Jenkins, R. B., Smith, D. I. & Liu, W., Jul 1998, In : International Journal of Oncology. 13, 1, p. 101-105 5 p.

Research output: Contribution to journalArticle

33 Scopus citations

Mutation and expression analysis of the p73 gene in prostate cancer

Yokomizo, A., Mai, M., Bostwick, D. G., Tindall, D. J., Qian, J., Cheng, L., Jenkins, R. B., Smith, D. I. & Liu, W., Apr 1 1999, In : Prostate. 39, 2, p. 94-100 7 p.

Research output: Contribution to journalArticle

35 Scopus citations

MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors

Singhi, A. D., Cimino-Mathews, A., Jenkins, R. B., Lan, F., Fink, S. R., Nassar, H., Vang, R., Fetting, J. H., Hicks, J., Sukumar, S., De Marzo, A. M. & Argani, P., Mar 2012, In : Modern Pathology. 25, 3, p. 378-387 10 p.

Research output: Contribution to journalArticle

51 Scopus citations

Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality

Ida, C. M., Rolig, K. A., Hulshizer, R. L., Van Dyke, D. L., Randolph, J. L., Jenkins, R. B., Nascimento, A. G. & Oliveira, A. M., Sep 2007, In : Cancer Genetics and Cytogenetics. 177, 2, p. 139-142 4 p.

Research output: Contribution to journalArticle

19 Scopus citations

Neuro-oncology practice: Understanding inherited genetic risk of adult glioma - A review

Rice, T., Lachance, D. H., Molinaro, A. M., Eckel-Passow, J. E., Walsh, K. M., Barnholtz-Sloan, J., Ostrom, Q. T., Francis, S. S., Wiemels, J., Jenkins, R. B., Wiencke, J. K. & Wrensch, M. R., Mar 20 2015, In : Neuro-Oncology Practice. 3, 1, p. 1-16 16 p., npv026.

Research output: Contribution to journalArticle

7 Scopus citations

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

Tse, B. W. C., Volpert, M., Ratther, E., Stylianou, N., Nouri, M., McGowan, K., Lehman, M. L., McPherson, S. J., Roshan-Moniri, M., Butler, M. S., Caradec, J., Gregory-Evans, C. Y., McGovern, J., Das, R., Takhar, M., Erho, N., Alshalafa, M., Davicioni, E., Schaeffer, E. M., Jenkins, R. B. & 14 others, Ross, A. E., Karnes, R. J., Den, R. B., Fazli, L., Gregory, P. A., Gleave, M. E., Williams, E. D., Rennie, P. S., Buttyan, R., Gunter, J. H., Selth, L. A., Russell, P. J., Nelson, C. C. & Hollier, B. G., Jan 16 2017, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

21 Scopus citations

Novel mutations of the MET proto-oncogene in papillary renal carcinomas

Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., Vocke, C., Brown, J. A., Jenkins, R. B., Richard, S., Bergerheim, U., Gerrard, B., Dean, M., Linehan, W. M. & Zbar, B., Apr 8 1999, In : Oncogene. 18, 14, p. 2343-2350 8 p.

Research output: Contribution to journalArticle

396 Scopus citations

Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas

Hartmann, C., Johnk, L., Sasaki, H., Jenkins, R. B. & Louis, D. N., 2002, In : Brain Pathology. 12, 2, p. 178-182 5 p.

Research output: Contribution to journalArticle

4 Scopus citations

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

Gurel, B., Iwata, T., Koh, C. M., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., Isaacs, W. B., Luo, J. & De Marzo, A. M., Sep 2008, In : Modern Pathology. 21, 9, p. 1156-1167 12 p.

Research output: Contribution to journalArticle

246 Scopus citations

Obesity and risk of esophageal adenocarcinoma and barrett's esophagus: A mendelian randomization study

Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium, Ashman, J. B., Bouras, E. P., Cassivi, S. D., Crowell, M. D., De Groen, P., Erlichman, C., Fitch, T. R., Fleischer, D. E., Foxx-Orenstein, A. E., Halling, K. C., Houghton, L. A., Keaveny, A. P., Locke, G. R. & Martenson, J. A., Nov 1 2014, In : Journal of the National Cancer Institute. 106, 11, dju252.

Research output: Contribution to journalArticle

70 Scopus citations

Oligodendroglial tumors with marked desmoplasia: Clinicopathologic and molecular features of 7 cases

Jentoft, M., Giannini, C., Rossi, S., Mota, R., Jenkins, R. B. & Rodriguez, F. J., Jun 2011, In : American Journal of Surgical Pathology. 35, 6, p. 845-852 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Oligodendroglioma cell lines containing t(1;19)(q10;p10)

Kelly, J. J. P., Blough, M. D., Stechishin, O. D. M., Chan, J. A. W., Beauchamp, D., Perizzolo, M., Demetrick, D. J., Steele, L., Auer, R. N., Hader, W. J., Westgate, M., Parney, I. F., Jenkins, R. B., Cairncross, J. G. & Weiss, S., Jul 2010, In : Neuro-Oncology. 12, 7, p. 745-755 11 p.

Research output: Contribution to journalArticle

49 Scopus citations

P16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Cen, L., Carlson, B. L., Schroeder, M. A., Ostrem, J. L., Kitange, G. J., Mladek, A. C., Fink, S. R., Decker, P. A., Wu, W., Kim, J. S., Waldman, T., Jenkins, R. B. & Sarkaria, J. N., Jul 2012, In : Neuro-Oncology. 14, 7, p. 870-881 12 p.

Research output: Contribution to journalArticle

90 Scopus citations

Papillary renal cell carcinoma: Analysis of germline mutations in the MET proto-oncogene in a clinic-based population

Lindor, N. M., Dechet, C. B., Greene, M. H., Jenkins, R. B., Zincke, M. T., Weaver, A. L., Wilson, M., Zincke, H. & Liu, W., 2001, In : Genetic Testing. 5, 2, p. 101-106 6 p.

Research output: Contribution to journalArticle

35 Scopus citations

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

Adem, C., Reynolds, C., Soderberg, C. L., Slezak, J. M., McDonnell, S. K., Sebo, T. J., Schaid, D. J., Myers, J. L., Sellers, T. A., Hartmann, L. C. & Jenkins, R. B., Jan 1 2003, In : Cancer. 97, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

61 Scopus citations
13 Scopus citations

P-glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response

McCollum, A. K., TenEyck, C. J., Stensgard, B., Morlan, B. W., Ballman, K. V., Jenkins, R. B., Toft, D. O. & Erlichman, C., Sep 15 2008, In : Cancer Research. 68, 18, p. 7419-7427 9 p.

Research output: Contribution to journalArticle

54 Scopus citations

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North central cancer treatment group study N0177

Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K. A., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., Kugler, J. W., Morton, R. F., Rowland, K. M., Mischel, P., Yong, W. H., Scheithauer, B. W., Schiff, D., Giannini, C. & Buckner, J. C., Dec 1 2008, In : Journal of Clinical Oncology. 26, 34, p. 5603-5609 7 p.

Research output: Contribution to journalArticle

191 Scopus citations

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402

Cairncross, G., Wang, M., Shaw, E., Jenkins, R. B., Brachman, D., Buckner, J. C., Fink, K., Souhami, L., Laperriere, N., Curran, W. & Mehta, M., Jan 20 2013, In : Journal of Clinical Oncology. 31, 3, p. 337-343 7 p.

Research output: Contribution to journalArticle

572 Scopus citations

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group trial 9402

Cairncross, G., Berkey, B., Shaw, E., Jenkins, R. B., Scheithauer, B., Brachman, D., Buckner, J. C., Fink, K., Souhami, L., Laperierre, N., Mehta, M. & Curran, W., Jun 20 2006, In : Journal of Clinical Oncology. 24, 18, p. 2707-2714 8 p.

Research output: Contribution to journalArticle

579 Scopus citations

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R. B., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG br0131

Vogelbaum, M. A., Berkey, B., Peereboom, D., Macdonald, D., Giannini, C., Suh, J. H., Jenkins, R. B., Herman, J., Brown, P., Blumenthal, D. T., Biggs, C., Schultz, C. & Mehta, M., Apr 2009, In : Neuro-Oncology. 11, 2, p. 167-175 9 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

Vogelbaum, M. A., Hu, C., Peereboom, D. M., Macdonald, D. R., Giannini, C., Suh, J. H., Jenkins, R. B., Laack, N. N., Brachman, D. G., Shrieve, D. C., Souhami, L. & Mehta, M. P., Jun 19 2015, In : Journal of Neuro-Oncology. 124, 3, p. 413-420 8 p.

Research output: Contribution to journalArticle

8 Scopus citations